Skip to main content
RPRX logo

RPRX · Royalty Pharma plc · Held by Funds

Track RPRX — free
$68.53 -0.79 (-1.13%) At close · Nov 16 Play latest call Q3 2026 earnings call transcript
Market Cap
$39.31B
Shares
573.61M
Volume · Nov 16 3.04M Avg daily vol (3M) 3.17M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of RPRX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 2.83% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.16% 938,479
Index ETFs 2.67% 15,291,433
Active ETFs 0.06% 338,130
Active funds 1.29% 7,406,081
Unclassified 0.02% 138,450
All registered funds 4.20% 24,112,573
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding RPRX

196 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 196 positions
Key facts CIK 1802768 CUSIP G7709Q104 13F (30d) 585 filings 556 filers Visit website Investor relations